EMA greenlights new COVID vaccine manufacturing site in France

Photo: EPA Medical staff prepare doses of Moderna COVID-19 vaccine

The European Medicines Agency has approved a new manufacturing site for the Moderna COVID-19 vaccine, in a move that could substantially boost production for the European Union.

In a statement on Friday, the EU drug regulator says it had approved a site in Monts, France, operated by Recipharm. In addition to the new site approval, the EMA authorised several other sites to conduct batch control and testing.

As reminded by AP, this month, two locations in the US were approved for production of vaccines destined for the 27-nation EU bloc. Any medicines or vaccines authorised for the EU market must first have their production facilities approved by the EMA.

The EMA says these new approved sites are expected to result in an additional 1 to 2 million vials of Moderna’s coronavirus vaccine every month.

Similar articles